Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2016
At a glance
- Drugs Sirolimus (Primary)
- Indications Tuberous sclerosis
- Focus Adverse reactions; Therapeutic Use
- 17 Aug 2016 Status changed from recruiting to completed.
- 03 Sep 2015 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 03 Sep 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Sep 2016 as reported by ClinicalTrials.gov.